Results 41 to 50 of about 316,189 (194)
Functional capabilities in patients with diabetic polyneuropathy [PDF]
, 2023 Аbstract: The research goal is to follow through the effect of kinesitherapy methods on functional disorders with diabetic polyneuropathy. Material and Methods: 11 patients with diagnosed diabetic polyneuropathy have been examined (6 women and 5 men ...
Lazova, Teodora, Vasileva, Dance
core +2 more sources
Effectiveness of thioctic acid drugs (Espa-lipon) in the treatment of diabetic polyneuropathy
Медицинский совет, 2015 This article tells about the treatment of diabetic polyneuropathy - the most common neurological complications of diabetes mellitus. The pathogenesis, diagnosis and current evidence-based treatments are described. Thioctic acid drugs for the treatment of
M. V. Nesterova, V. V. Galkin
doaj +1 more source
Balkan Journal of Medical Genetics, 2023 Vascular complications are the leading cause of increased morbidity and mortality of diabetic patients. It has been postulated that matrix metalloproteinases MMP-2 and MMP-9, zinc-dependent endopeptidases through remodeling of the extracellular matrix ...
Andjelic Jelic M +6 more
doaj +1 more source
, 2017 Purpose: To assess the relationship between diabetic polyneuropathy (DPN) and the risk of diabetic retinopathy (DR). Methods: From 1997 to 2010, we identified 5031 newly diagnosed DPN patients and 20 124 controls matched for sex, age, and index year ...
王一中 +1 more
core +1 more source
HereditasBackground The incidence of diabetic peripheral neuropathy (DPN) is increasing every year for type 2 diabetes mellitus (T2DM) patients, and diabetic polyneuropathy is a common type.
Ruixing Liu +4 more
doaj +1 more source
Cells, 2021 Dental pulp stem cells (DPSCs) are suitable for use in regenerative medicine. Cryopreserved human DPSCs (hDPSCs) ameliorate diabetic polyneuropathy, and the effects of hDPSC transplantation are related to VEGF and NGF secretion.
Masaki Hata +19 more
doaj +1 more source
Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini +9 more
wiley +1 more source
ПРИНЦИПЫ ПАТОГЕНЕТИЧЕСКОЙ ТЕРАПИИ ДИАБЕТИЧЕСКОЙ АВТОНОМНОЙ НЕЙРОПА ТИИ
Архивъ внутренней медицины, 2012 According to WHO interpretation diabetic polyneuropathy, or chronic sensorimotor polyneuropathy, distal symmetrical polyneuropathy is a condition characterized by progressive loss of nerve fibers, leading to loss of sensation and the development of foot ...
А. А. Михайлов
doaj +1 more source
Update on the management of diabetic polyneuropathies
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2011 The prevalence of diabetic polyneuropathy (DPN) can approach 50% in subjects with longer-duration diabetes. The most common neuropathies are generalized symmetrical chronic sensorimotor polyneuropathy and autonomic neuropathy. It is important to recognize that 50% of subjects with DPN may have no symptoms and only careful clinical examination may ...
Shakher,Jayadave, Stevens,Martin J
openaire +4 more sources
Advancing Human Skin Equivalents: The Crucial Role of Neurovascular Integration
Advanced Healthcare Materials, EarlyView.This review discusses the importance of integrating vascular and peripheral nerve systems into human skin equivalents (HSEs) to better recapitulate native skin physiology. Recent advances in vascularized, innervated, and neurovascularized HSEs are highlighted, together with emerging bioengineering strategies, current challenges, and future ...
Hao Wu +4 more
wiley +1 more source